that would be nice but would have thought optimistic. I like...

that would be nice but would have thought optimistic. I like that they have enough cash to see them through to end 2019.

If i have the figures correct:

Each APAS sale brings approx US $300k so x 5 this year would make $1.5M . half of that goes the Clever Culture Systems. then LBT get $20k from each machine each year thereafter. It is still not big sales $$ but signals to the market this is the way of the future an because there are so many labs that are processing big numbers of samples each day it stands to reason they will follow in time. at this point in time I am not aware of an automated competitor so speed and being fIrst In market will be a massive advantage. wIth all the govt approvals and patents (for a would-be competItor) requIred to compete, It should gIve LBT a good chance to establIsh as the market leader. the momentum over the next 6 month wIll hopefully gIve the market confIdence (restore trust) and the SP wIll run.

hopefully we will have a buyer for Woundvue and that should be a nice $ kicker. am kind of sad they are selling that tho- it is the closest thing to a Star Trek tri-corder that Is on the horizon. pretty cool potential.

exploring the other markets for testing samples and making an announcement about progress in another industry would also be good cause for SP to run IMHO. the low Interest loan from govt put to good use would be great to see here.

here's hopIng for good news soon! DYOR